NAKATA Katsuhiko | Research Laboratory, Santen Pharmaceutical Co., Ltd.
スポンサーリンク
概要
関連著者
-
Iso Tadashi
Research Laboratory Santen Pharmaceutical Co. Ltd.
-
NAKATA Katsuhiko
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
Yamauchi Hideyasu
Research Laboratory Santen Pharmaceutical Co. Ltd.
-
Suda Hiroshi
Research Laboratory Santen Pharmaceutical Co. Ltd.
-
YAMAUCHI HIDEYASU
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
NISHIMURA Kazuo
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
IWAO Jun-ichi
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
SUDA HIROSHI
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
IWATANI Terumichi
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
HORIUCHI Masato
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
KITO Hirokazu
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
SUDA Hiroshi
Research Institute for Wakan-yaku, Toyama Medical and Pharmaceutical University
著作論文
- A NEW POTENT INHIBITOR OF CONVERTING ENZYME: (2R, 4R)-2-(2-HYDROXYPHENYL)-3-(3-MERCAPTOPROPIONYL)-4-THIAZOLIDINECARBOXYLIC ACID(SA446)
- Species difference of (2R,4R)-2-(o-Hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid (SA446) in inhibition of angiotensin converting enzyme.
- Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96). 3. Effects of SA96 on experimental allergic reactions.